Vaccine Approval Insights

Early signals for COVID-19 vaccines are promising, but significant work remains ahead. The FDA's emergency use authorization (EUA) process is designed to ensure rigorous standards, especially in light of past experiences with other treatments that lacked strong evidence. The emphasis on vaccine safety and efficacy is paramount, and the public can feel more reassured about the vaccine's integrity as the FDA raises the bar for approval.